Cognizant’s Healthcare Quality Engine, TriZetto® ClaimSphere® has received its 9th Consecutive HEDIS® (Healthcare Effectiveness Data and Information Set) Measure Certification from the National Committee for Quality Assurance (NCQA).
NCQA certification validates that ClaimSphere quality measures have passed the rigorous testing to support health plans for the 2019 HEDIS reporting season. Cognizant is also a NCQA certified vendor for Integrated Healthcare Association’s Align. Measure. Perform (AMP) program used by organizations across California to drive meaningful changes that reduce costs and improve healthcare quality and outcomes.
“Cognizant’s consistent certification of our ClaimSphere platform validates our ongoing commitment to driving a population-focused approach towards quality management with our customers,” said Kaushik Bhaumik, Executive Vice President and Global Leader, Cognizant Healthcare. “Cognizant’s healthcare software solutions help organizations enhance revenue growth, drive administrative efficiency, improve cost and quality of care and enhance member and patient experience. Our mission to help our customers improve their ratings, meet current regulatory success and improve the quality of their services remains paramount to our collaborative success.”
ClaimSphere is integrated with Cognizant’s market leading Facets® and QNXT™ core systems enabling clients to identify and publish gaps in care intelligence in near real-time.
This year Cognizant has also certified its Machine Learning and Quality Reporting Document Architecture (QRDA)-enabled Big Data Engine, ClaimSphere® QaaS Prime. It is aligned with FHIR standards and can be used to run over 1,000 measure algorithms including eCQM and MIPS.
Recognized by KLAS in 2017 for providing a full quality improvement offering, the ClaimSphere suite includes HEDIS regulatory reporting, gaps in care intelligence, star analytics, service bureau support, and advisory & clinical services. It is currently implemented within healthcare organizations throughout the U.S. and is estimated to cover 1 in 20 lives across Medicare, Medicaid and commercial lines of business.
For more information, click here.